Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Novel CRF1-specific ligands claimed by Neurogen

Nov. 24, 1998

Pyridazine and phthalazine derivatives from SmithKline Beecham for CNS, neurological disorders

Nov. 24, 1998

Dual 5-HT reuptake inhibitor/5-HT1A antagonist discussed at neuroscience meeting

Nov. 24, 1998

Sch-50971: a novel histamine H3 agonist with antimigraine and sedative effects in preclinical models

Nov. 23, 1998

MK-0869 effective and well tolerated in patients with major depressive disorder

Nov. 23, 1998

Cytogen and Berlex finalize supply agreement with DuPont for Quadramet

Nov. 23, 1998

Pharmacia & Upjohn's reboxetine now available in Spain

Nov. 23, 1998

Neuroprotective effects and mode of action of Ono-2506 detailed at recent meeting

Nov. 20, 1998

New warnings issued for Tasmar; E.U. suspends use

Nov. 20, 1998

Antihyperalgesic effects of SB-235863 presented at Society for Neuroscience meeting

Nov. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.